Literature DB >> 8992980

Visualization of antigen-specific T cell activation and cytokine expression in vivo.

W O Rogers1, C T Weaver, L A Kraus, J Li, L Li, R P Bucy.   

Abstract

A transgenic TCR adoptive transfer system was used to visualize Ag-specific T cell activation and cytokine expression in vivo. After s.c. injection of peptide in adjuvant the entire Ag-specific population up-regulated IL-2 receptor alpha-chain expression, underwent blast transformation, and developed a memory-surface phenotype. A minority of the Ag-specific T cells produced predominantly IL-2 mRNA and localized at the T cell/B cell junction in draining lymph nodes. In the secondary response, a mixed cytokine pattern of both Th1 and Th2 cytokines was demonstrated. When peptide was administered i.v. without adjuvant, 50% of the Ag-specific cells expressed IL-2, but the peak of expression occurred before IL-2 receptor alpha-chain up-regulation, and only a minority of the Ag-specific T cells underwent blast transformation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8992980

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Polyfunctional responses by human T cells result from sequential release of cytokines.

Authors:  Qing Han; Neda Bagheri; Elizabeth M Bradshaw; David A Hafler; Douglas A Lauffenburger; J Christopher Love
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-12       Impact factor: 11.205

2.  Naive T-cell receptor transgenic T cells help memory B cells produce antibody.

Authors:  Darragh Duffy; Chun-Ping Yang; Andrew Heath; Paul Garside; Eric B Bell
Journal:  Immunology       Date:  2006-11       Impact factor: 7.397

3.  The secretory IFN-gamma response of single CD4 memory cells after activation on different antigen presenting cell types.

Authors:  Patrick A Ott; Magdalena Tary-Lehmann; Paul V Lehmann
Journal:  Clin Immunol       Date:  2007-07-13       Impact factor: 3.969

4.  Bolus injection of aqueous antigen leads to a high density of T-cell-receptor ligand in the spleen, transient T-cell activation and anergy induction.

Authors:  S K Switzer; B P Wallner; T J Briner; G H Sunshine; C R Bourque; M Luqman
Journal:  Immunology       Date:  1998-08       Impact factor: 7.397

Review 5.  Heterogeneity in the clonal T cell response. Implications for models of T cell activation and cytokine phenotype development.

Authors:  C T Weaver; A Saparov; L A Kraus; W O Rogers; R D Hockett; R P Bucy
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

6.  Antigen-specific T helper cell function: differential cytokine expression in primary and memory responses.

Authors:  J F Panus; L J McHeyzer-Williams; M G McHeyzer-Williams
Journal:  J Exp Med       Date:  2000-11-06       Impact factor: 14.307

7.  A natural immunological adjuvant enhances T cell clonal expansion through a CD28-dependent, interleukin (IL)-2-independent mechanism.

Authors:  A Khoruts; A Mondino; K A Pape; S L Reiner; M K Jenkins
Journal:  J Exp Med       Date:  1998-01-19       Impact factor: 14.307

8.  Subretinal delivery of adeno-associated virus serotype 2 results in minimal immune responses that allow repeat vector administration in immunocompetent mice.

Authors:  Susie E Barker; Cathryn A Broderick; Scott J Robbie; Yanai Duran; Mythili Natkunarajah; Prateek Buch; Kamaljit S Balaggan; Robert E MacLaren; James W B Bainbridge; Alexander J Smith; Robin R Ali
Journal:  J Gene Med       Date:  2009-06       Impact factor: 4.565

9.  Restricted clonal expression of IL-2 by naive T cells reflects differential dynamic interactions with dendritic cells.

Authors:  Vincent Hurez; Arman Saparov; Albert Tousson; Michael J Fuller; Takekazu Kubo; James Oliver; Benjamin T Weaver; Casey T Weaver
Journal:  J Exp Med       Date:  2003-06-30       Impact factor: 14.307

10.  Genetic regulation of commitment to interleukin 4 production by a CD4(+) T cell-intrinsic mechanism.

Authors:  M Bix; Z E Wang; B Thiel; N J Schork; R M Locksley
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.